Navigation Links
Confronting Influenza: Are We Prepared?

"Confronting Influenza: Are We Prepared?" A Symposium Presented by The Howard Hughes Medical Institute and The Center for Strategic and International Studies.

The Howard Hughes Medical Institute (HHMI) and the Center for Strategic and International Studies (CSIS) cordially invite you to attend a symposium on the current state of research, development of prophylactic and therapeutic treatments, and U.S. and global strategies aiming to manage both annual and possible global pandemic influenza outbreaks.

World-renowned speakers will include:

  • Stephen C. Harrison, HHMI Investigator and Professor of Biological Chemistry and Molecular Pharmacology, Professor of Pediatrics and Director of the Harvard-Armenise Center for Structural Biology at Harvard Medical School; and Head of the Laboratory of Molecular Medicine at Children's Hospital, Boston;
  • Dominick A. Iacuzio, Medical Director at Hoffman-La Roche, Inc;
  • Robert A. Lamb, HHMI Investigator and John Evans Professor of Molecular and Cellular Biology at Northwestern University, Evanston, and Professor of Microbiology-Immunology at Northwestern University Medical School;
  • Peter Palese, Chairman and Professor, Department of Microbiology, Mt. Sinai School of Medicine;
  • Timothy M. Uyeki, Medical Epidemiologist, Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention; and
  • Robert G. Webster, Rose Marie Thomas Chair, Division of Virology, St. Jude Children's Research Hospital; Consultant to the World Health Organization (WHO) and the National Institute of Allergy and Infectious Diseases (NIAID); and Director of the U.S. Collaborating Center of the WHO dealing with the ecology of animal influenza viruses.

    Discussion topics will include the structure of the influenza viral proteins and the relevance of that structure for drug development, lessons learned from the 1918 pandemic, current H5N1 (Avia
    '"/>



    • Source:Howard Hughes Medical Institute


    Page: 1 2

    Related biology news :

    1. RNA project to create language for scientists worldwide
    2. Disease diagnosis, biodefense among UH chemical research projects
    3. New project aims to make large-scale lobster farms feasible
    4. New Scripps Oceanography project to study sediments and ecosystem restoration in Venice lagoon
    5. ‘Blue Brain?project explores thought at molecular level
    6. Grand Challenges in Global Health initiative funds Yale project
    7. Virtual microscopy project wins educational technology award
    8. St. Jude projects 90 percent cure rate for ALL
    9. UCLA study of community health project shows how group dynamics affect fitness, eating habits
    10. Large-scale genomics project will hunt genes behind common childhood diseases
    11. Ground spider diversity studied in research project

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    		TAG: Confronting Influenza Are Prepared

    (Date:11/6/2009)...with their arboreal hosts. But new research sugges...of choice, the ants can get destructive to neighbo...ember issue of the American Naturalist , is the f...nd it reopens a centuries-old debate on the relati...in species of plants and trees have cozy relations...
    (Date:11/5/2009)...ning grant in the amount of $2,756,719 by the Nati...uation Education and Research Training (IGERT) pro...to Kent State. The grant, which is funded under th...runs through 2014. , The grant funds an IGERT pr... sensing (EARS). The purpose of the program is to ...
    (Date:11/4/2009)... hold the power to help militaries and munitions m...c waste on test sites. , Compounds known as nitr...rld War II and have been used in military munition...ten used to propel tank shells and act like a more... knowledge of their environmentally harmful effect...
    Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Genomic research will enable greener cleanup of military explosive test sites 2Switching early breast cancer patients to exemestane improves long term survival 57884 1Switching early breast cancer patients to exemestane improves long term survival 57884 2Prince Albert II of Monaco Foundation helps fund Field Museum conservation efforts in Peru 10013 1Prince Albert II of Monaco Foundation helps fund Field Museum conservation efforts in Peru 10013 2Julio Palmaz to Present at the 2009 TCT Conference 57879 1Julio Palmaz to Present at the 2009 TCT Conference 57879 2
    ...y Assistance (AOA), a comprehensive, multi-faceted..."cap" on out-of-pocket co-payments for cancer pati...h AOA, patients who are uninsured, underinsured, o...l receive help obtaining financial support for Amg...ng cancer is expensive and our industry needs to f...
    ...ully so your buddy can get some tail may seem like...rds, it also gives a fascinating peek into hard-wi...hed lizards spend their year on earth looking to r...evolution. An article in the May 9 edition of the ...ovides the first genetic evidence of a trait that ...
    ...oteins in the brains of individuals addicted to co...nd mechanisms that may one day lead to new treatme...rted in the current issue of Molecular Psychiatry,...mounts of 50 proteins and point to profound change...se, said Scott E. Hemby, Ph.D., of Wake Forest Uni...
    Other Biology News:Amgen introduces comprehensive financial assistance programs for cancer patients 2Nice guys do finish first in lizards' evolutionary race 2High-tech research shows cocaine changes proteins and brain function 2
    (Date:11/6/2009)...Intarcia Therapeutics, Inc. delivered two presenta...s delivery of exenatide) program for the treatment...echnology Meeting in San Francisco, CA: ,, (Log...FTU126LOGO ) ,, Continuous Subcutaneous Deliv...e, HbA1c and Reduces Weight in a 28-day Phase 1b S...
    (Date:11/5/2009)... DSM Pharmaceutical Products today announced that ... Saint Jean D,Illac, France, where DSM will be the...for Galenix commercial products on a global basis....s development opportunities co-marketing Galenix d...f Galenix in drug product development and clinical...
    (Date:11/5/2009)...Call/ -- BioSpecifics Technologies Corp. (Nasdaq: ...rst-in-class collagenase-based products, today ann... ended September 30, 2009. ,, "We were extreme...s Arthritis Advisory Committee unanimously recomme...M) for the treatment of Dupuytren,s disease, and w...
    (Date:11/5/2009)...ineSmith Partners has signed an initial agreement ...d that mimics the structure of natural cancellous ...products by SpineSmith,s Research and Development ...fold represents a significant advancement in techn...for the delivery of adult stem cells for skeletal ...
    Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
    ... closing condition to merger with Raven ...ISCO, Calif., Dec. 20 VaxGen,Inc. (Pink Sheets: V... that,it has, along with Punk Ziegel and Company, ...on stock for quotation on the OTC Bulletin Board, ...the year under the symbol VXGN.,Further, VaxGen an...
    ...rma is pleased to announce the,fall conference lin...are,impacting the pharmaceutical industry today. T...tional and networking opportunities for Clinical,M... large to small,pharmaceutical, biotech and medica...on some of the featured events and highlights,from...
    ...Roche has Filed an IND With the US FDA for a ..., August 10 Genmab A/S (OMX: GEN),announced today...al New,Drug application (IND) with the US Food and...ed under the companies, collaboration. Genmab will... not influence Genmab,s,financial guidance for 200...
    Other Biology Technology:VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 2VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 3VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 4Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharma's Fall Line Up! 2Roche Files IND for Second Genmab Antibody 2
    Finnpipette BioControl Multichannel, 8 Channel 5-50ul from Thermo Scientific
    Acl I (Psp1406 I) from New England Biolabs
    Mouse Anti-Human Cystatin A Monoclonal Antibody, Unconjugated, Clone 224705 from R&D Systems
    Acc I from Takara Mirus Bio
    Biology Products: